DRUG RESISTANT MUTATIONS DETECTED BY GENOTYPIC DRUG RESISTANCE TESTING IN PATIENTS FAILING THERAPY IN CLADE C HIV-1 INFECTED INDIVIDUALS FROM INDIA

Abstract

Resistance testing to check the prevalence of drug resistance mutations that arise following failure of the first line regimen to establish guidelines for second line regimens in India is a must. Studies are needed to confirm if mutation patterns that arise among clade C following failure of ART are the same as for clade B strains.